跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Rapcenate - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Rapcenate
Approved
STANDARD
Rapcenate
Azarias Pharmaceutical Laboratories Inc.,
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
0ac8046fb5542a44
Company
Azarias Pharmaceutical Laboratories Inc.,
Type
Standard
Approval Details
Approval Id
0ac8046fb5542a44
Drug Approval Philippines Name
Rapcenate
Product Name
Rapcenate
Registration Number
DRP-14229
Brand Name
Rapcenate
Generic Name
Calcium Carbonate
Dosage Form
Tablet
Dosage Strength
500 mg
Manufacturer
Azarias Pharmaceutical Laboratories Inc.,
Trader
St. Raphael Archangel Pharmaceutical Product Distribution
Issuance Date
31 July 2023
Expiry Date
31 July 2028
Classification
Over-the-Counter (OTC) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
0ac8046fb5542a44
Type
Standard
Back to Philippines FDA Approvals